|
Name |
Cinnamoylglycine
|
Molecular Formula | C11H11NO3 | |
IUPAC Name* |
2-[[(E)-3-phenylprop-2-enoyl]amino]acetic acid
|
|
SMILES |
C1=CC=C(C=C1)/C=C/C(=O)NCC(=O)O
|
|
InChI |
InChI=1S/C11H11NO3/c13-10(12-8-11(14)15)7-6-9-4-2-1-3-5-9/h1-7H,8H2,(H,12,13)(H,14,15)/b7-6+
|
|
InChIKey |
YAADMLWHGMUGQL-VOTSOKGWSA-N
|
|
Synonyms |
Cinnamoylglycine; 16534-24-0; N-Cinnamoylglycine; 2-Cinnamamidoacetic acid; N-Cinnamylglycine; 2-[(2E)-3-phenylprop-2-enamido]acetic acid; 62430-40-4; 2-[[(E)-3-phenylprop-2-enoyl]amino]acetic acid; CHEBI:68616; Glycine,N-(1-oxo-3-phenyl-2-propen-1-yl)-; N-[(2E)-3-phenylprop-2-enoyl]glycine; N-(1-oxo-3-phenyl-2-propenyl)-Glycine; N-(1-oxo-3-phenyl-2-propen-1-yl)-Glycine; Glycine, N-(1-oxo-3-phenyl-2-propen-1-yl)-; N-cinnamoyl-Glycine; 2-Cinnamamidoaceticacid; Glycine, N-cinnamoyl-; Glycine, N-cinnamoyl-, E-; CHEMBL456606; SCHEMBL1558162; SCHEMBL9309519; ZINC99385; HMS1447M06; 2-(3-Phenylacrylamido)acetic acid; CS-M1704; STL363041; AKOS000203043; CCG-245338; IDI1_017289; CS-13471; HY-77641; Glycine, N-(1-oxo-3-phenyl-2-propenyl)-; EN300-10753; N-(2-Hydroxy-2-oxoethyl)-3-phenylpropenamide; AB00082962-01; EN300-1448663; N-Cinnamoylglycine, analytical reference material; Q27137048; Z56883153; ECED132A-EF7F-427F-A985-F27822E561C9; C551E21D-9A7D-40AE-83A5-11794CD47554
|
|
CAS | 16534-24-0 | |
PubChem CID | 709625 | |
ChEMBL ID | CHEMBL456606 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 205.21 | ALogp: | 1.2 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.4 | Aromatic Rings: | 1 |
Heavy Atoms: | 15 | QED Weighted: | 0.728 |
Caco-2 Permeability: | -4.886 | MDCK Permeability: | 0.00001970 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.52 | 20% Bioavailability (F20%): | 0.418 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.869 | Plasma Protein Binding (PPB): | 50.09% |
Volume Distribution (VD): | 0.216 | Fu: | 47.03% |
CYP1A2-inhibitor: | 0.054 | CYP1A2-substrate: | 0.086 |
CYP2C19-inhibitor: | 0.053 | CYP2C19-substrate: | 0.058 |
CYP2C9-inhibitor: | 0.059 | CYP2C9-substrate: | 0.088 |
CYP2D6-inhibitor: | 0.161 | CYP2D6-substrate: | 0.125 |
CYP3A4-inhibitor: | 0.011 | CYP3A4-substrate: | 0.151 |
Clearance (CL): | 2.854 | Half-life (T1/2): | 0.858 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.389 |
Drug-inuced Liver Injury (DILI): | 0.704 | AMES Toxicity: | 0.858 |
Rat Oral Acute Toxicity: | 0.125 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.786 | Carcinogencity: | 0.18 |
Eye Corrosion: | 0.307 | Eye Irritation: | 0.956 |
Respiratory Toxicity: | 0.147 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001091 | 0.622 | D01ZJK | 0.622 | ||||
ENC004807 | 0.515 | D07ONP | 0.393 | ||||
ENC001615 | 0.479 | D03KOZ | 0.389 | ||||
ENC001616 | 0.463 | D0R1CR | 0.364 | ||||
ENC000023 | 0.449 | D0E6OC | 0.363 | ||||
ENC000684 | 0.429 | D0G2MH | 0.350 | ||||
ENC000054 | 0.429 | D0X9RY | 0.340 | ||||
ENC001428 | 0.422 | D00DZN | 0.339 | ||||
ENC002014 | 0.421 | D05OFX | 0.333 | ||||
ENC004716 | 0.421 | D06LHG | 0.333 |